Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 30331501000001118 | Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 30331601000001119 | Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category Schedule 2 (CD) | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | Is pack of | Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | Has active ingredient | Opium | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | Has active ingredient | Scopolamine hydrobromide | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | Has active ingredient | Papaveretum | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | Has VMP | Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | Has specific active ingredient | Scopolamine hydrobromide | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | Has specific active ingredient | Papaveretum | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | Has dispensed dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | Has VMP | Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule | Has VMP | Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | true | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR